Skip to main content
Premium Trial:

Request an Annual Quote

UPDATE: Proteome Systems to Collaborate With Cancer Researcher at University of Missouri-Columbia

NEW YORK, June 21 - Proteome Systems and researchers at the University of Missouri-Columbia have agreed to jointly identify and study the proteins involved in resistance to cancer drugs using the company's proteomics platform, the company said Thursday.

Stephen Alexander, a molecular biologist at the university who has collaborated with Proteome Systems for almost 20 years, will use the slime mold Dictyostelium discoideum  as a model system for studying the organism's cellular response to anticancer drugs. 

Alexander said that his group will provide the biological expertise and the samples to Proteome Systems, which will employ its high-throughput 2-D gel electrophoresis and mass spectrometry platform to identify and characterize the proteins in the sample. 

Because D. discoideum  has about 15,000 genes, Alexander said, his group and researchers at Proteome Systems will be able to study the expressed proteins within a reasonable time frame. Alexander said the company has committed to funding his research for one year, but that the collaboration should last at least three years.

Having Proteome Systems fund the project is important Alexander added, because in general NIH would not fund a project focused predominantly on discovery science. 

In a statement, Jenny Harry, the vice president for discovery at Sydney, Australia-based Proteome Systems, said that the Alexander group brings "a new perspective to solving problems in cancer. We are delighted to be working with a group of scientists who understand the value of proteomics to accelerate the discovery process."

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.